Literature DB >> 25367751

Squalene emulsion potentiates the adjuvant activity of the TLR4 agonist, GLA, via inflammatory caspases, IL-18, and IFN-γ.

Anthony L Desbien1, Steven J Reed, Hilton R Bailor, Natasha Dubois Cauwelaert, John D Laurance, Mark T Orr, Christopher B Fox, Darrick Carter, Steven G Reed, Malcolm S Duthie.   

Abstract

The synthetic TLR4 agonist glucopyranosyl lipid adjuvant (GLA) is a potent Th1-response-inducing adjuvant when formulated in a squalene oil-in-water emulsion (SE). While the innate signals triggered by TLR4 engagement are well studied, the contribution of SE remains unclear. To better understand the effect of SE on the adjuvant properties of GLA-SE, we compared the innate and adaptive immune responses elicited by immunization with different formulations: GLA without oil, SE alone or the combination, GLA-SE, in mice. Within the innate response to adjuvants, only GLA-SE displayed features of inflammasome activation, evidenced by early IL-18 secretion and IFN-γ production in memory CD8(+) T cells and neutrophils. Such early IFN-γ production was ablated in caspase-1/11(-/-) mice and in IL-18R1(-/-) mice. Furthermore, caspase-1/11 and IL-18 were also required for full Th1 CD4(+) T-cell induction via GLA-SE. Thus, we demonstrate that IL-18 and caspase-1/11 are components of the response to immunization with the TLR4 agonist/squalene oil-in-water based adjuvant, GLA-SE, providing implications for other adjuvants that combine oils with TLR agonists.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Adjuvants; Innate immunity; Squalene; TLR4; Th1 immunity

Mesh:

Substances:

Year:  2014        PMID: 25367751     DOI: 10.1002/eji.201444543

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  30 in total

1.  How squalene GLAdly helps generate antigen-specific T cells via antigen-carrying neutrophils and IL-18.

Authors:  Justin D Kedl; Ross M Kedl
Journal:  Eur J Immunol       Date:  2015-02       Impact factor: 5.532

2.  CD11a and CD49d enhance the detection of antigen-specific T cells following human vaccination.

Authors:  Allison F Christiaansen; Upasna Gaur Dixit; Rhea N Coler; Anna Marie Beckmann; Steven G Reed; Patricia L Winokur; M Bridget Zimmerman; Steven M Varga; Mary E Wilson
Journal:  Vaccine       Date:  2017-06-27       Impact factor: 3.641

3.  Intratumoral G100, a TLR4 Agonist, Induces Antitumor Immune Responses and Tumor Regression in Patients with Merkel Cell Carcinoma.

Authors:  Shailender Bhatia; Natalie J Miller; Hailing Lu; Natalie V Longino; Dafina Ibrani; Michi M Shinohara; David R Byrd; Upendra Parvathaneni; Rima Kulikauskas; Jan Ter Meulen; Frank J Hsu; David M Koelle; Paul Nghiem
Journal:  Clin Cancer Res       Date:  2018-08-09       Impact factor: 12.531

4.  IL-18 and Subcapsular Lymph Node Macrophages are Essential for Enhanced B Cell Responses with TLR4 Agonist Adjuvants.

Authors:  Anthony L Desbien; Natasha Dubois Cauwelaert; Steven J Reed; Hilton R Bailor; Hong Liang; Darrick Carter; Malcolm S Duthie; Christopher B Fox; Steven G Reed; Mark T Orr
Journal:  J Immunol       Date:  2016-10-28       Impact factor: 5.422

Review 5.  Adjuvant formulations for virus-like particle (VLP) based vaccines.

Authors:  Velasco Cimica; Jose M Galarza
Journal:  Clin Immunol       Date:  2017-08-03       Impact factor: 3.969

6.  A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against Zika.

Authors:  Jesse H Erasmus; Amit P Khandhar; Jeff Guderian; Brian Granger; Jacob Archer; Michelle Archer; Emily Gage; Jasmine Fuerte-Stone; Elise Larson; Susan Lin; Ryan Kramer; Rhea N Coler; Christopher B Fox; Dan T Stinchcomb; Steven G Reed; Neal Van Hoeven
Journal:  Mol Ther       Date:  2018-08-02       Impact factor: 11.454

Review 7.  Development of a schistosomiasis vaccine.

Authors:  Adebayo J Molehin; Juan U Rojo; Sabrina Z Siddiqui; Sean A Gray; Darrick Carter; Afzal A Siddiqui
Journal:  Expert Rev Vaccines       Date:  2016-01-13       Impact factor: 5.217

8.  Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses.

Authors:  Emilie Seydoux; Hong Liang; Natasha Dubois Cauwelaert; Michelle Archer; Nicholas D Rintala; Ryan Kramer; Darrick Carter; Christopher B Fox; Mark T Orr
Journal:  J Immunol       Date:  2018-05-16       Impact factor: 5.422

Review 9.  Correlates of GLA family adjuvants' activities.

Authors:  Steven G Reed; Darrick Carter; Corey Casper; Malcolm S Duthie; Christopher B Fox
Journal:  Semin Immunol       Date:  2018-10-23       Impact factor: 11.130

10.  Inclusion of an Optimized Plasmodium falciparum Merozoite Surface Protein 2-Based Antigen in a Trivalent, Multistage Malaria Vaccine.

Authors:  Jacqueline S Eacret; Elizabeth M Parzych; Donna M Gonzales; James M Burns
Journal:  J Immunol       Date:  2021-03-31       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.